Chronic hypertension overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
:::    Stage 1: systolic 140-159 mmHg or diastolic 90-99 mmHg
:::    Stage 1: systolic 140-159 mmHg or diastolic 90-99 mmHg
:::    Stage 2: systolic ≥160 or diastolic ≥100 mmHg
:::    Stage 2: systolic ≥160 or diastolic ≥100 mmHg
Hypertension can be classified as either '''essential''' (primary) or '''secondary'''. Essential hypertension indicates that no specific medical cause can be found to explain a patient's condition. [[Secondary hypertension]] indicates that the high blood pressure is a result of (i.e. secondary to) another condition, such as [[kidney disease]] or certain [[tumor]]s (especially of the [[adrenal gland]]). Even moderate elevation of arterial blood pressure leads to shortened life expectancy.  At severely high pressures, mean arterial pressures 50% or more above average, a person can expect to live no more than just a few years unless appropriately treated.<ref>Textbook of Medical Physiology, 7th Ed., Guyton & Hall, Elsevier-Saunders, ISBN 0-7216-0240-1, page 220.</ref>


Hypertension is one of the most common diseases afflicting humans worldwide, estimated to have a prevalence of as many as 1 billion individuals, and causing 7.1 million deaths per year.<ref name="pmid14656957">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | journal=Hypertension | year= 2003 | volume= 42 | issue= 6 | pages= 1206-52 | pmid=14656957 | doi=10.1161/01.HYP.0000107251.49515.c2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14656957  }} </ref> Hypertension is the most important modifiable risk factor for [[coronary heart disease]] (the leading cause of death in North America), [[stroke]] (the third leading cause), [[congestive heart failure]], peripheral vascular disease, and is a leading cause of [[chronic renal failure]]. Despite the prevalence and associated complications of hypertension, control of the disease is still exceedingly insufficient.  
Hypertension is one of the most common diseases afflicting humans worldwide, estimated to have a prevalence of as many as 1 billion individuals, and causing 7.1 million deaths per year.<ref name="pmid14656957">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | journal=Hypertension | year= 2003 | volume= 42 | issue= 6 | pages= 1206-52 | pmid=14656957 | doi=10.1161/01.HYP.0000107251.49515.c2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14656957  }} </ref> Hypertension is the most important modifiable risk factor for [[coronary heart disease]] (the leading cause of death in North America), [[stroke]] (the third leading cause), [[congestive heart failure]], peripheral vascular disease, and is a leading cause of [[chronic renal failure]]. Despite the prevalence and associated complications of hypertension, control of the disease is still exceedingly insufficient.  
Hypertension can be classified as either '''essential''' (primary) or '''secondary'''. Essential hypertension indicates that no specific medical cause can be found to explain a patient's condition. [[Secondary hypertension]] indicates that the high blood pressure is a result of (i.e. secondary to) another condition, such as [[kidney disease]] or certain [[tumor]]s (especially of the [[adrenal gland]]). Even moderate elevation of arterial blood pressure leads to shortened life expectancy.  At severely high pressures, mean arterial pressures 50% or more above average, a person can expect to live no more than just a few years unless appropriately treated.<ref>Textbook of Medical Physiology, 7th Ed., Guyton & Hall, Elsevier-Saunders, ISBN 0-7216-0240-1, page 220.</ref>


The purpose of a hypertensive patient evaluation is to identify other cardiovascular risk factors that may affect prognosis and guide treatment, find any identifiable causes of high blood pressure, and determine the presence or extent of target organ damage and cardiovascular disease. Patients with hypertension are evaluated through medical history, physical examination, routine laboratory tests and other diagnostic procedures. In order to properly diagnose a patient, the recommended laboratory tests include a 12-lead [[electrocardiogram]]; [[urinalysis]]; [[blood glucose]] and [[hematocrit]]; [[serum potassium]], [[creatinine]], [[electrolytes]], and [[uric acid]]; and a [[lipoprotein]] profile (after 9- to 12-hour fast).<ref name="pmid14656957">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | journal=Hypertension | year= 2003 | volume= 42 | issue= 6 | pages= 1206-52 | pmid=14656957 | doi=10.1161/01.HYP.0000107251.49515.c2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14656957  }} </ref> Additional diagnostic tests may be performed to reveal causes of hypertension particularly in the event that a patient's medical history and examinations indicate a cause, blood pressure is unresponsive to drug treatment, blood pressure increases after being controlled, or onset was sudden. Currently, testing for [[microalbuminuria]] is limited primarily to patients with diabetes in order to screen for early nephropathy. The main indication for [[echocardiography]] is to detect suspected end-organ damage in a patient with borderline blood pressure values, who may not otherwise be treated based solely on clinical criteria.   
The purpose of a hypertensive patient evaluation is to identify other cardiovascular risk factors that may affect prognosis and guide treatment, find any identifiable causes of high blood pressure, and determine the presence or extent of target organ damage and cardiovascular disease. Patients with hypertension are evaluated through medical history, physical examination, routine laboratory tests and other diagnostic procedures. In order to properly diagnose a patient, the recommended laboratory tests include a 12-lead [[electrocardiogram]]; [[urinalysis]]; [[blood glucose]] and [[hematocrit]]; [[serum potassium]], [[creatinine]], [[electrolytes]], and [[uric acid]]; and a [[lipoprotein]] profile (after 9- to 12-hour fast).<ref name="pmid14656957">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | journal=Hypertension | year= 2003 | volume= 42 | issue= 6 | pages= 1206-52 | pmid=14656957 | doi=10.1161/01.HYP.0000107251.49515.c2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14656957  }} </ref> Additional diagnostic tests may be performed to reveal causes of hypertension particularly in the event that a patient's medical history and examinations indicate a cause, blood pressure is unresponsive to drug treatment, blood pressure increases after being controlled, or onset was sudden. Currently, testing for [[microalbuminuria]] is limited primarily to patients with diabetes in order to screen for early nephropathy. The main indication for [[echocardiography]] is to detect suspected end-organ damage in a patient with borderline blood pressure values, who may not otherwise be treated based solely on clinical criteria.   

Revision as of 19:27, 30 June 2011

Hypertension Main page

Overview

Causes

Classification

Primary Hypertension
Secondary Hypertension
Hypertensive Emergency
Hypertensive Urgency

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor in Chief: Firas Ghanem, M.D. and Atif Mohammad, M.D.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hypertension, commonly referred to as "high blood pressure" or HTN, is a medical condition in which the blood pressure is chronically elevated.[1] While it is formally called arterial hypertension, the word "hypertension" without a qualifier usually refers to arterial hypertension.

In 2003, the Joint National Committee provided a seventh report (JNC 7) which suggested the following definitions based upon the average of two or more properly measured readings at each of two or more visits after an initial screen[2]:

  • Normal blood pressure: systolic <120 mmHg and diastolic <80 mmHg
  • Prehypertension: systolic 120-139 mmHg or diastolic 80-89 mmHg
  • Hypertension:
Stage 1: systolic 140-159 mmHg or diastolic 90-99 mmHg
Stage 2: systolic ≥160 or diastolic ≥100 mmHg

Hypertension can be classified as either essential (primary) or secondary. Essential hypertension indicates that no specific medical cause can be found to explain a patient's condition. Secondary hypertension indicates that the high blood pressure is a result of (i.e. secondary to) another condition, such as kidney disease or certain tumors (especially of the adrenal gland). Even moderate elevation of arterial blood pressure leads to shortened life expectancy. At severely high pressures, mean arterial pressures 50% or more above average, a person can expect to live no more than just a few years unless appropriately treated.[3]

Hypertension is one of the most common diseases afflicting humans worldwide, estimated to have a prevalence of as many as 1 billion individuals, and causing 7.1 million deaths per year.[4] Hypertension is the most important modifiable risk factor for coronary heart disease (the leading cause of death in North America), stroke (the third leading cause), congestive heart failure, peripheral vascular disease, and is a leading cause of chronic renal failure. Despite the prevalence and associated complications of hypertension, control of the disease is still exceedingly insufficient.

The purpose of a hypertensive patient evaluation is to identify other cardiovascular risk factors that may affect prognosis and guide treatment, find any identifiable causes of high blood pressure, and determine the presence or extent of target organ damage and cardiovascular disease. Patients with hypertension are evaluated through medical history, physical examination, routine laboratory tests and other diagnostic procedures. In order to properly diagnose a patient, the recommended laboratory tests include a 12-lead electrocardiogram; urinalysis; blood glucose and hematocrit; serum potassium, creatinine, electrolytes, and uric acid; and a lipoprotein profile (after 9- to 12-hour fast).[4] Additional diagnostic tests may be performed to reveal causes of hypertension particularly in the event that a patient's medical history and examinations indicate a cause, blood pressure is unresponsive to drug treatment, blood pressure increases after being controlled, or onset was sudden. Currently, testing for microalbuminuria is limited primarily to patients with diabetes in order to screen for early nephropathy. The main indication for echocardiography is to detect suspected end-organ damage in a patient with borderline blood pressure values, who may not otherwise be treated based solely on clinical criteria.

Hypertension is the most common primary diagnosis in America.[4] Initial treatment for hypertension generally involves lifestyle modifications (nonpharmacologic therapy), which is also critical for prevention of the disease. Modifications encouraged for hypertensive patients include moderate dietary salt restriction, maintain body weight or weight reduction in obese patients, increased intake of fruits and vegetables and low-fat dairy products, limited alcohol intake, and regular aerobic exercise. Although effective blood pressure control can be achieved in most patients with hypertension, the majority will require 2 or more antihypertensive drugs.[4]

There are three main classes of drugs that are used for initial monotherapy (when no specific indication requires other treatment methods): thiazide diuretics, long-acting calcium channel blockers (most often a dihydropyridine), and ACE inhibitors or angiotensin II receptor blockers. In some cases, particularly with patients having moderate to severe hypertension, single agent therapy does not control the blood pressure. Over time, patients who were initially controlled with monotherapy need to increase medication to a combined therapy in order for continued blood pressure control. The primary determinant of the outcome is the attained blood pressure, not the specific drug(s) used. The goal of antihypertensive therapy in patients with uncomplicated combined systolic and diastolic hypertension is a blood pressure of below 140/90 mmHg.

References

  1. Template:KMLEref
  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
  3. Textbook of Medical Physiology, 7th Ed., Guyton & Hall, Elsevier-Saunders, ISBN 0-7216-0240-1, page 220.
  4. 4.0 4.1 4.2 4.3 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.

Template:WH

Template:WS